Omron (OTCMKTS:OMRNY) Stock Price Up 5.9% – Time to Buy?

Omron Corp. (OTCMKTS:OMRNY)’s share price rose 5.9% during mid-day trading on Friday . The company traded as high as $33.11 and last traded at $33.06. Approximately 4,672 shares traded hands during mid-day trading, a decline of 91% from the average daily volume of 49,645 shares. The stock had previously closed at $31.2150.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Omron from a “strong sell” rating to a “hold” rating in a report on Monday, January 19th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Omron presently has a consensus rating of “Hold”.

Omron Trading Up 2.0%

The company has a market capitalization of $6.89 billion, a price-to-earnings ratio of 42.28, a price-to-earnings-growth ratio of 0.62 and a beta of 0.98. The firm has a fifty day moving average price of $26.63 and a 200-day moving average price of $26.72. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.40 and a current ratio of 2.14.

Omron (OTCMKTS:OMRNY) last announced its quarterly earnings data on Thursday, February 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.19). The firm had revenue of $1.41 billion for the quarter, compared to analyst estimates of $1.38 billion. Omron had a return on equity of 2.46% and a net margin of 2.80%.Omron has set its FY 2025 guidance at 0.960-0.960 EPS. As a group, equities analysts anticipate that Omron Corp. will post 0.42 EPS for the current year.

Institutional Investors Weigh In On Omron

An institutional investor recently raised its position in Omron stock. GAMMA Investing LLC grew its holdings in Omron Corp. (OTCMKTS:OMRNY) by 50.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 2,129 shares of the company’s stock after purchasing an additional 716 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $54,000 as of its most recent SEC filing. Institutional investors own 1.09% of the company’s stock.

About Omron

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.